TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks PARP enzyme activity and traps ...
MedPage Today on MSNOpinion

The physician and the peripheral brain

What are the risks and benefits of deskilling as AI use in medicine grows?
A 2026 study redefines functional high-risk multiple myeloma early detection, shifting the relapse benchmark from 18 to 36 ...
Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...